Medeliver Intracranial Drug Coated Balloon Catheter Clinical Trial for Symptomatic Intracranial Stenosis
ClinicalTrials.gov Studies
Summary
Beijing Jiu Shi Shen Kang Medical Technology Co., Ltd. registered a clinical trial (NCT07542938) on ClinicalTrials.gov evaluating the Medeliver® Intracranial Drug-Coated Balloon Catheter for endovascular treatment of symptomatic intracranial atherosclerotic stenosis. The trial enrolls participants receiving either the Medeliver® drug-coated balloon or the Diveroad® intracranial balloon dilatation catheter as interventions.
“To evaluate the safety and efficacy of the Medeliver® Intracranial Drug-Coated Balloon Catheter (developed by Beijing Jiu Shi Shen Kang Medical Technology Co., Ltd.) in the endovascular treatment of symptomatic intracranial atherosclerotic stenosis.”
What changed
Clinical trial registration NCT07542938 describes a Phase N/A study by Beijing Jiu Shi Shen Kang Medical Technology Co., Ltd. evaluating the safety and efficacy of the Medeliver® Intracranial Drug-Coated Balloon Catheter for symptomatic intracranial atherosclerotic stenosis. The trial lists two interventions: the Medeliver® drug-coated balloon catheter and the Diveroad® intracranial balloon dilatation catheter. This is a registration entry on ClinicalTrials.gov and does not constitute regulatory approval, authorization, or any compliance obligation.
Archived snapshot
Apr 21, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Medeliver Intracranial Drug Coated Balloon Catheter for Symptomatic Intracranial Atherosclerotic Stenosis
N/A NCT07542938 Kind: NA Apr 21, 2026
Abstract
To evaluate the safety and efficacy of the Medeliver® Intracranial Drug-Coated Balloon Catheter (developed by Beijing Jiu Shi Shen Kang Medical Technology Co., Ltd.) in the endovascular treatment of symptomatic intracranial atherosclerotic stenosis.
Conditions: Symptomatic Intracranial Atherosclerotic Stenosis
Interventions: Intracranial Drug-Coated Balloon Catheter (Medeliver®), Intracranial Balloon Dilatation Catheter (Diveroad®)
Mentioned entities
Related changes
Get daily alerts for ClinicalTrials.gov Studies
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov Studies publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.